[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 2 (3-2020) ::
Caspian J Intern Med 2020, 11(2): 5-0 Back to browse issues page
Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
Maral Seyed Ahadi , Abdorreza Naser Moghadasi , Nasrin Asgari , Mohammad Ali Sahraian
Multiple Sclerosis Research Center; Neuroscience institute; Tehran University of Medical Sciences; Tehran; Iran , sahraian1350@yahoo.com
Abstract:   (313 Views)
This article has no abstract.
Keywords: Neuromyelitis Optica Spectrum Disorders, Rituximab, CD19+ B cell, EDSS, Annualized Relapse Rate
     
Type of Study: Original Article | Subject: Neurology
Received: 2019/05/3 | Accepted: 2019/12/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seyed Ahadi M, Naser Moghadasi A, Asgari N, Sahraian M A. Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.. Caspian J Intern Med. 2020; 11 (2) :5-0
URL: http://caspjim.com/article-1-1877-en.html


Volume 11, Issue 2 (3-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 31 queries by YEKTAWEB 4075